MVG
DNA icon

Madrona Venture Group’s Ginkgo Bioworks DNA Stock Holding History

Madrona Venture Group’s Portfolio DNA Stock Details DNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$353K Hold
42,430
– – 1.6% 3
2025
Q3 		$619K Hold
42,430
– – 4.47% 3
2025
Q2 		$477K Buy
+42,430
New +$329K 3.78% 3

Other funds holding DNA

Viking Global Investors
Viking Global Investors Stamford, Connecticut $35.1B AUM 21.36% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $12.9B AUM 52.69% 1-Year Est. Return
ACG
Anchorage Capital Group New York $450M AUM 41.75% 1-Year Est. Return
Legal & General Group
Legal & General Group London, United Kingdom $480B AUM 42.84% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JMFC
J.M. Forbes & Co Boston, Massachusetts $1.27B AUM 26.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Madrona Venture Group's DNA Position: Q4 2025 in Review

Madrona Venture Group held its Ginkgo Bioworks (DNA) position steady in Q4 2025 at 42,430 shares worth $353K. The position accounts for 1.6% of the portfolio, ranked #3.

Madrona Venture Group first reported a position in DNA in Q2 2025 and has held it in 3 quarters since. The position peaked at $619K in Q3 2025. 181 funds tracked by Wall St. Rank hold DNA as of Q4 2025.

  • Madrona Venture Group held 42,430 shares of Ginkgo Bioworks worth $353K as of Q4 2025.
  • Madrona Venture Group left its Ginkgo Bioworks share count unchanged in Q4 2025.
  • Ginkgo Bioworks made up 1.6% of Madrona Venture Group's portfolio in Q4 2025, its #3 holding.
  • Madrona Venture Group first reported a position in Ginkgo Bioworks in Q2 2025 and has held it in 3 quarters since.
  • Madrona Venture Group's Ginkgo Bioworks position peaked at $619K in Q3 2025.
  • 181 funds tracked by Wall St. Rank held Ginkgo Bioworks as of Q4 2025.

Based on Madrona Venture Group's 13F filing for Q4 2025, filed 13 Feb 2026.